Skip to main content

Breast cancer, version 3.2013: featured updates to the NCCN guidelines.

Publication ,  Journal Article
Theriault, RL; Carlson, RW; Allred, C; Anderson, BO; Burstein, HJ; Edge, SB; Farrar, WB; Forero, A; Giordano, SH; Goldstein, LJ; Gradishar, WJ ...
Published in: J Natl Compr Canc Netw
July 2013

These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

July 2013

Volume

11

Issue

7

Start / End Page

753 / 760

Location

United States

Related Subject Headings

  • Recurrence
  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Molecular Targeted Therapy
  • Humans
  • Female
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Theriault, R. L., Carlson, R. W., Allred, C., Anderson, B. O., Burstein, H. J., Edge, S. B., … National Comprehensive Cancer Network, . (2013). Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw, 11(7), 753–760. https://doi.org/10.6004/jnccn.2013.0098
Theriault, Richard L., Robert W. Carlson, Craig Allred, Benjamin O. Anderson, Harold J. Burstein, Stephen B. Edge, William B. Farrar, et al. “Breast cancer, version 3.2013: featured updates to the NCCN guidelines.J Natl Compr Canc Netw 11, no. 7 (July 2013): 753–60. https://doi.org/10.6004/jnccn.2013.0098.
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, et al. Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Jul;11(7):753–60.
Theriault, Richard L., et al. “Breast cancer, version 3.2013: featured updates to the NCCN guidelines.J Natl Compr Canc Netw, vol. 11, no. 7, July 2013, pp. 753–60. Pubmed, doi:10.6004/jnccn.2013.0098.
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung B-ME, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R, National Comprehensive Cancer Network. Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Jul;11(7):753–760.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

July 2013

Volume

11

Issue

7

Start / End Page

753 / 760

Location

United States

Related Subject Headings

  • Recurrence
  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Molecular Targeted Therapy
  • Humans
  • Female
  • Breast Neoplasms